Trial Profile
Metastatic Sarcoma Tumors Study CSTI571BUS124
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Aug 2006
Price :
$35
*
At a glance
- Drugs Imatinib (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- Sponsors Novartis
- 14 Aug 2006 New trial record.